title: Clarification on the impact of cervarix vaccination on human papillomavirus infection and cervical cancer in the United Kingdom.
authors: a Department of Medicine , Indiana University School Of Medicine , Indianapolis , IN , USA.
authors: Darron
authors: D
authors: Brown
authors: b Merck & Co, Inc , Kenilworth , NJ , USA.
authors: Amit Sharad
authors: AS
authors: Kulkarni
authors: b Merck & Co, Inc , Kenilworth , NJ , USA.
authors: Matt
authors: M
authors: Pillsbury
authors: b Merck & Co, Inc , Kenilworth , NJ , USA.
authors: Alain
authors: A
authors: Luxembourg
authors: b Merck & Co, Inc , Kenilworth , NJ , USA.
authors: Alfred
authors: A
authors: Saah
mesh_terms: D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D030361:Papillomavirus Infections; D053918:Papillomavirus Vaccines; D006113:United Kingdom; D002583:Uterine Cervical Neoplasms; D014611:Vaccination
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines; C510352:human papillomavirus vaccine, L1 type 16, 18